11-67490965-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_003977.4(AIP):c.965C>T(p.Ala322Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,609,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003977.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AIP | NM_003977.4 | c.965C>T | p.Ala322Val | missense_variant | Exon 6 of 6 | ENST00000279146.8 | NP_003968.3 | |
AIP | NM_001302959.2 | c.788C>T | p.Ala263Val | missense_variant | Exon 6 of 6 | NP_001289888.1 | ||
AIP | NM_001302960.2 | c.*105C>T | 3_prime_UTR_variant | Exon 6 of 6 | NP_001289889.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152254Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000420 AC: 10AN: 237902Hom.: 0 AF XY: 0.0000538 AC XY: 7AN XY: 130094
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1457190Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 724616
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152254Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74386
ClinVar
Submissions by phenotype
AIP-related disorder Uncertain:1
The AIP c.965C>T variant is predicted to result in the amino acid substitution p.Ala322Val. This variant was reported as a variant of uncertain significance in a patient with breast cancer diagnosed before age 45 (DataSheet 1, Gifoni et al 2022. PubMed ID: 35957908). This variant is reported in 0.0074% of alleles in individuals of European (non-Finnish) descent in gnomAD and is interpreted as a variant of uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/41216/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 322 of the AIP protein (p.Ala322Val). This variant is present in population databases (rs267606586, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with AIP-related conditions. ClinVar contains an entry for this variant (Variation ID: 41216). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt AIP protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Somatotroph adenoma Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at